Background: Radical vaginal trachelectomy (RVT) is a fertility-preserving operation for young women who have cervical cancer in an early stage and want to have children. The demand for RVT is increasing, because more than 40% of all cases of cervical carcinoma affect women under the age of 44. Women are increasingly having their first child at later ages.
C ervical cancer is the second most common malignant disease in women (1) . Increasingly, young women with no children are affected. In Germany, 8.2 out of 100 000 women between the ages of 20 and 40 are diagnosed with cervical cancer every year (2) .
Data collected in 2009 shows that 14.9% of these women are between 20 and 34 years of age and 26.2% are between 35 and 44 years old (3) (4) (5) . Simultaneously, the age of the primigravida went up. Women between the ages of 20 and 29 are having fewer children whilst women over 30 increasingly become mothers (6) . Therefore, it is important to offer women with cervical cancer in the early stages (tumor ≤ 2cm, FIGO stage IA1 to IB1, V0, pN0) who wish to conceive a treatment that preserves fertility. Preserving fertility has a positive influence on quality of life whereas infertility as a result of cancer treatment has the opposite effect (7) (8) (9) (10) . The majority of women with early cervical cancer are treated with hysterectomy. A pregnancy then becomes impossible for these patients.
An alternative treatment, established by Daniel Dargent, is the radical vaginal removal of the cervix (radical vaginal trachelectomy [RVT] ) combined with laparoscopic removal of lymph nodes (11) .
RVT involves the removal of two-thirds of the cervix with a small vaginal cuff and a third to half of the neighboring parametrium. A cervical cerclage is then performed (Figure 1 ).
In the last decade it was shown that RVT to preserve fertility is a safe alternative to radical hysterectomy from an oncological perspective. A number of retrospective studies (12, 13) show that the rates of recurrence and survival after RVT are similar or even superior to those following radical hysterectomy (14) (15) (16) (17) (18) (19) . Radical removal of the cervix should be discussed with patients as a possible alternative therapy if preserving fertility is desirable. About 50% of all fertile women with a diagnosis of early stage cervical cancer fit the criteria for a radical vaginal trachelectomy (20) .
Methods
The results of a prospective analysis of 300 women who were operated on by us are part of this review. The data includes 17 years of therapy and post-operative care of women with radical trachelectomy. It also includes a review of the safety of the operating technique, oncological results (disease free and overall survival [DFS/OS]), fertility, pregnancy and health of the baby. In addition, a selective literature search in Medline via PubMed was done and the current recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie (Working Group on Gynecological Oncology) are incorporated.
In addition to our results, personally communicated recommendations as well as results of discussions of the Task Force Fertility Preservation of the European Society of Gynaecological Oncology (ESGO) have been included in the analysis.
Development of radical trachelectomy
As early as 1973 operations were reported that were similar to the later radical trachelectomy (RVT) (21) . The first formal operation plan of a radical vaginal trachelectomy was developed by Daniel Dargent (11) . His method to treat women with early cervical carcinoma in FIGO stage IA1 to IIA with radical vaginal trachelectomy combined with laparoscopic removal of pelvic lymph nodes was published in 1994. Since then, the indications, the adjuvant and neoadjuvant therapy, the choice of patients, the pre-operative staging, the surgical technique and the post-operative follow-up have been continuously critically evaluated and improved. Most data relating to RVT is collected retrospectively in specialized gynecological oncology treatment centers. The quality of the surgery and the experience of the surgeon are of great importance for the oncological results and the outcome of subsequent pregnancies (14, 17, 21, 22) . There are no randomized controlled trials regarding oncological outcomes of RVT compared with radical hysterectomy. Participating in a study of this kind is not feasible for women who wish to preserve fertility (16) .
Current indications and oncological safety
In the current recommendations of the German Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG), RVT is mentioned as a treatment option for patients with squamous cell carcinoma or adenocarcinoma of the cervix in FIGO stage IA1 L1 V0, stage IA2 V0 or stage IB1 V0 ≤ 2 cm who wish to conceive.
Neuroendocrine cervical cancer is more often associated with recurrence, distant metastasis and lower five-year survival rates and is therefore not suitable for RVT. This is similar if histopathological examination has shown that the tumor has invaded the blood vessels. In addition, a pre-condition for RVT is to prove that the pelvic lymph nodes are free of cancer by histopathological examination (Figure 1 ). Adhering to these inclusion criteria is very important for oncological safety. In the early stages of the development of the RVT it was assumed that tumors up to FIGO stage IIA can be treated in this way. It soon became clear that the size of the tumor is of great importance for oncological safety (15) . Studies in recent years have shown that oncological safety of RVT regarding recurrence rates and mortality are comparable to the more radical 
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Marchiole (15) Plante (31) Shepherd (19) Hertel (14) Covens (13) Sonoda (20) Schlaerth (26) Dargent (28) Mathevet (39) Burnett (27) Lanowska ( treatment with radical hysterectomy in patients with a tumor diameter of ≤ 2cm and invasion of the connective tissue of less than 10 mm without invasion of the lymph nodes (Table 1 ) (14, 17, 18, (22) (23) (24) (25) (26) (27) (28) . The recurrence rates are in the range of 2% to 5% and the mortality rates are 3% to 6% and are different in different groups. All data were collected retrospectively (14, 22) . In contrast to the data of other groups, we evaluated the cohort of women post RVT prospectively. It seems that adenocarcinomas have a higher rate of recurrence but so far it has not been possible to prove this with statistical significance (13) . In this study, the five-year survival rate without recurrence following RVT is 95% and for radical hysterectomy 100%, if the cervix carcinoma was FIGO stage IB1. RVT in combination with laparoscopic removal of lymph nodes is currently the standard operation for fertility-preserving surgery for cervical cancer and worldwide more than 1000 operations have been performed (10) . One of the important factors for survival without recurrence is the expertise of the surgeon. The RVT should be performed in a center specialized in this technique to ensure the best possible peri-and postoperative care for the patient (14) . One problem with existing studies was the lack of follow-up of these young, mobile patients. We had a cohort of 225 patients post RVT (up until 03/2010) and could follow up 212 women (95%) prospectively and obtained data regarding oncology and fertility. All patients had the standard surgery (14, 17, 20, 22) and standard followup (22) . The standard follow-up includes a review every three months for the first two years after surgery, and then every six months for the next three years. After five years, an annual follow-up is recommended. The follow-up is usually done by the gynecologist and in our trachelectomy follow-up clinic using a follow-up protocol developed by our team (colposcopy, HPVswab etc.).
Fertility and pregnancy
Examining fertility and pregnancy data shows that patients and professionals are uncertain about pregnancy following trachelectomy.
Of the 212 patients treated by us, 76 patients (35.8%) were planning a pregnancy at the time when the data was collected (0-5 years following surgery) (29) . According to this, most patients were not planning a pregnancy at this stage. Professionals and patients are unsure about the prognosis of a pregnancy. It was also shown that, as a result of the cancer diagnosis, planning a pregnancy became a secondary consideration for patients, despite receiving fertility-preserving surgery.
The patients under our care show no decline in fertility following RVT: 50 out of 76 women who were trying to conceive were successful (65.8%) (29) . The pregnancy rate for all patients following RVT is 24% which is comparable with the pregnancy rate in Rob et al. of 30% (11) . The really important number, however, is how many patients would like to be pregnant and it is this number which shows the true success rate following trachelectomy (30, 34) . In the unselected population 85.4% will conceive within 12 months if they are trying to conceive (4) .
In the group examined by us, 50 women had a total of 60 pregnancies and 45 live births during the study period (29) . Other authors report similar rates (30, 31, 35) (Table 2) . Of the women who were planning to conceive, only those who had already had fertility problems or failed to conceive prior to trachelectomy had problems afterwards. Possible changes that might influence fertility which are caused by the surgery itself are: reduced cervical mucus; adhesions; reduced blood flow through the uterus, fallopian tubes and ovaries; or cervical stenosis (30) (31) (32) (33) (34) (35) (36) . The reduction in fertility caused by the surgery itself seems minimal.
Of the 60 pregnancies in our study, five resulted in miscarriage in the first trimester; one woman had an ectopic pregnancy. The rate of first trimester miscarriages following RVT was lower than the rate in the unselected population (8.4% versus 14-20%). In the second trimester, miscarriage was more common-three patients had a late miscarriage-and this rate is comparable with rates in the unselected population (5% post RVT versus 4% in the normal population) (34) . In the group studied by Shepherd et al. (37) the rate of early miscarriage was notably higher (22/88) . Also the number of late miscarriages was markedly increased (12/88) ( Table 2 ). The data published by Plante et al. (30, 31, 38 ) is similar to ours. There is no suggestion that hormonal treatment to improve fertility alters the oncological results after RVT (39, 40) . Two pregnant patients chose to terminate the pregnancy.
The greatest challenge post RVT is not to achieve pregnancy but to reduce the increased rate of preterm labor (29) (30) (31) (32) (33) (34) .
Nearly 50% of patients post trachelectomy reached the 37 th week of gestation and had therefore a term delivery (29-32). Of the live births, three were before the 28 th week of gestation and 15 women had their babies between the 28 th and 36 th weeks of gestation (29) . Most of the preterm deliveries therefore occurred after the 32 nd week of gestation. Following RVT only 10% of babies were born before the 28 th week of gestation. The main reason for preterm delivery was premature rupture of the amniotic membranes with chorioamnionitis.
The babies examined by us were in good health and had no additional problems resulting from their prematurity or the RVT undergone by their mothers. Postnatal morbidity compared to a control group was slightly reduced which might be explained by the intensive antenatal care (e1).
Recommendations in pregnancy
To standardize and simplify antenatal care for women after radical vaginal trachelectomy (RVT) of the cervix, we developed an 18-point recommendation to support health professionals and patients (Box 2). These recommendations go further than the recommendations based on three case studies by Knight et al. in 2010 (e2) .
All pregnancies following RVT are high-risk pregnancies. Women should wait at least three months after RVT before a pregnancy to allow complete healing of the wounds. Despite the incidence of recurrence of the cancer being higher in the first two years post surgery, there is currently no indication that a pregnancy is a contributory factor. The patient must be made aware by the surgeon that a delivery can only be done by Cesarean section which should be done in a perinatology unit.
Antenatal care should be offered according to the antenatal care guidelines of the Bundesausschuss der Ärzte und Krankenkassen (German National Committee of Physicians and Health Insurers).
Dental treatment should not be undergone in pregnancy to avoid bacteremia. Because of the mechanical manipulation and the increased rate of urinary tract infections and vaginal infections, the couple should be Schlaerth (26) Shepherd (24) Burnett (27) Dargent (28) Shepherd (37) Plante (38) Hertel (14) Speiser (29) The patient should be shown how to check her own vaginal pH to test the function of the vaginal flora as a barrier against infection. The pH value should be between 4 and 4.5.
Gynecological examinations should be done under sterile conditions. For pregnant women post RVT we recommend weekly speculum examinations and vaginal ultrasound to measure the length of the remaining cervix. Swabs to check for bacterial and fungal infections and a microscopic film should be done every four weeks. In the case of abnormal results, systemic treatment according to resistance is recommended.
Digital vaginal examinations should be avoided. The indications for total occlusion of the cervix are previous preterm birth or recurrent miscarriage, similar to other pregnancies. These patients should also be offered an abdominal cerclage-if not pregnant, by a laparoscopy or, if pregnant, by laparotomy (bikini-line incision). This seems reasonable despite the fact that all patients received a permanent cerclage during the RVT to support the remaining cervix. A general recommendation for total occlusion of the cervix is not supported by current data.
We recommend time off work from the 12 th week of gestation onwards unless the patient has a stress-free office job. Until the 20 th week of gestation the patient should avoid physical strain (no sport, no heavy lifting >2 kg, but not bed rest). Between the 20 th and 28 th weeks of gestation the patient should take even greater care. Patients who have premature contractions, cervical incompetence, bleeding or difficult social circumstances should be admitted as in-patients. Oral progesterone of 200 mg three times a day to avoid early miscarriages is suggested. If a delivery is expected between the 23+6 and 34+0 weeks of gestation betamethasone should be given to support maturing of the fetal lungs. Giving antibiotics prophylactically has only been proven useful if there is premature labor or proven infection, prophylactic benefit has not been proven outside these indications (e3). 
Conclusion
Since it was first described by Daniel Dargent, radical vaginal trachelectomy in the hands of an experienced surgeon has been developed into an oncologically safe technique for women with early stage cervical carcinoma who wish to preserve fertility. Our team has operated more than 300 patients with this method and worldwide there are more than 1000 patients. There have been 300 pregnancies. Most babies were born after the 37 th week of gestation. There is still a high percentage of preterm birth following trachelectomy.
There is a lack of information among doctors and patients about pregnancies following trachelectomy. Our recommendations are designed to help patients post trachelectomy who wish to conceive to feel more confident. They also should help to create the conditions for a successful pregnancy. The aim of the recommendation is to reduce the rate of preterm birth further by standardizing antenatal care. If complications occur during pregnancy after RVT these should be clearly documented and analyzed to improve knowledge about pregnancies after trachelectomy. 
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KEY MESSAGES
• Radical vaginal trachelectomy (RVT) is a fertilitypreserving surgical technique for young women with a desire to conceive who have been diagnosed with cervical cancer in the early stages.
• The oncological safety of the radical removal of the cervix is similar to that of radical hysterectomy.
• If trying to conceive, the rate of conception after RVT is only marginally below the rate of conception of the unselected population.
• Out of 1000 women worldwide who were treated with RVT, so far 300 pregnancies occurred. About 50% of the babies were born after the 37 th week of gestation; 90% of the babies were born after the 28 th week of gestation.
• Following the recommendations for management of pregnancies post RVT should further reduce the rate of pre-term deliveries. Translated from the original German by Dr Ute Semrau-Boughton,
